News

Kadrige is engaged in forming a team of consultants, sales professionals, project managers and information technology engineers for marketing range of services with a plan to enable biopharma

Following the termination, the Nordic region’s distribution rights will again go back to Oasmia Pharma. Oasmia Pharma has developed a water soluble formulation of Paclitaxel with the retinoid

The tie up allows the US based company to carry forward the clinical development, manufacturing and commercialization of VR315 product. Vectura will provide support for the US development

The 505(b)(2) filing of NDA was supported by the results from a Phase 3 Freedom-301 clinical trial and an open-label, safety extension which was intended to investigate overall

Cephalon‘s net income was $115.19m, compared to $92.39m for the same period in the prior year. The company’s income from operations was $148.39m for the second quarter ended

Under the new deal, NPS will be responsible for filing applications for two of GSK’s experimental calcilytic compounds, SB-423557 and SB-423562 (NPSP790 and NPSP795). The new agreement will

CPI-300, a novel antidepressant, with a high strength of bupropion hydrochloride (HCl), is the active ingredient in Wellbutrin XL. Pillar5 has responded to all queries from the FDA

Zoely, a monophasic combination of 2 steroid hormones – 17-beta estradiol and nomegestrol acetate, will be made available in a convenient 24 day active and 4 day placebo

The integrated content along with T SystemEV aids providers with extensive drug and clinical data to improve the accuracy and safety of patient care for adult and pediatric